Skip to main content
Home
  • About
    • Board of Directors
    • Our Staff
    • Annual Reports
    • Policies
    • Fellowship
    • Careers
  • Projects
    • Column 1
      • Animal Health & Veterinary Medicine
        • Antimicrobial Use in Food Animals
        • Industry SWOT Analysis
      • Expanded Access
        • E-request App
        • Navigator
        • Resources for COVID-19
      • FDA Patient Listening Sessions
      • Food & Nutrition
        • About
        • Food Traceability
        • Healthy Rule Roundtables
        • Nutrition Facts Label
        • Produce Safety Stakeholder Dialogue
        • Retail Dietitian Toolkit
    • Column 2
      • Improving Access to FDA Information
        • Understanding FDA & FDA-Regulated Products
        • Improving Access to Publicly Available FDA Information
      • Research
        • About
        • Cross-Sectoral Health Threats
        • IMEDS
          • IMEDS Inquiry
        • Post Market Research
        • RAISE
        • Real World Data
        • Regulatory Science Accelerator
      • Substance Use Disorders
  • News and Events
    • Innovations in Regulatory Science & Policy Awards
    • 2024 Annual Public Meeting
    • Events
    • News
    • Publications
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
      1. Board of Directors
      2. Our Staff
      3. Annual Reports
      4. Policies
      5. Fellowship
      6. Careers
  • Projects
      1. Column 1
        1. Animal Health & Veterinary Medicine
          1. Antimicrobial Use in Food Animals
          2. Industry SWOT Analysis
        2. Expanded Access
          1. E-request App
          2. Navigator
          3. Resources for COVID-19
        3. FDA Patient Listening Sessions
        4. Food & Nutrition
          1. About
          2. Food Traceability
          3. Healthy Rule Roundtables
          4. Nutrition Facts Label
          5. Produce Safety Stakeholder Dialogue
          6. Retail Dietitian Toolkit
      2. Column 2
        1. Improving Access to FDA Information
          1. Understanding FDA & FDA-Regulated Products
          2. Improving Access to Publicly Available FDA Information
        2. Research
          1. About
          2. Cross-Sectoral Health Threats
          3. IMEDS
          4. Post Market Research
          5. RAISE
          6. Real World Data
          7. Regulatory Science Accelerator
        3. Substance Use Disorders
  • News and Events
      1. Innovations in Regulatory Science & Policy Awards
      2. 2024 Annual Public Meeting
      3. Events
      4. News
      5. Publications
  • Expanded Access eRequest

A Phase 2 Study of RTB101 as COVID-19 Post-Exposure Prophylaxis in Older Adults

  • Read more about A Phase 2 Study of RTB101 as COVID-19 Post-Exposure Prophylaxis in Older Adults

Lung Structure-Function In Survivors of Mild and Severe COVID-19 Infection

  • Read more about Lung Structure-Function In Survivors of Mild and Severe COVID-19 Infection

Post Acute COVID-19 Quality of Life (PAC-19QoL) Tool Development and Patient Registry (PAC-19QoLReg)

  • Read more about Post Acute COVID-19 Quality of Life (PAC-19QoL) Tool Development and Patient Registry (PAC-19QoLReg)

VEGF and SFlt-1 Levels in the Pathogenesis and Severity of COVID-19 Disease

  • Read more about VEGF and SFlt-1 Levels in the Pathogenesis and Severity of COVID-19 Disease

Clinical and Mechanistic Study of Patients (With COVID-19 or Not) With a Recent Acrosyndrome

  • Read more about Clinical and Mechanistic Study of Patients (With COVID-19 or Not) With a Recent Acrosyndrome

The COVID-RASi Trial (COVID-19)

  • Read more about The COVID-RASi Trial (COVID-19)

French Cohort of COVID-19 Patients With Post-intensive Care Syndrome

  • Read more about French Cohort of COVID-19 Patients With Post-intensive Care Syndrome

Late Clinical Events Associated With COVID-19 Infection

  • Read more about Late Clinical Events Associated With COVID-19 Infection

Myeloid Cells in Patients With Covid-19 Pneumonia

  • Read more about Myeloid Cells in Patients With Covid-19 Pneumonia

Impact of a Monoamine Oxidase Inhibitor on the Phenotype of Blood Mononucleated Cells in Patients With COVID-19

  • Read more about Impact of a Monoamine Oxidase Inhibitor on the Phenotype of Blood Mononucleated Cells in Patients With COVID-19

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 221
  • Page 222
  • Page 223
  • Page 224
  • Current page 225
  • Page 226
  • Page 227
  • Page 228
  • Page 229
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
admin@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA